Chengda biology: a total of 23976 winning results were released

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

Cambridge Industries Group Plans Optical Module Capacity Expansion Across Four Countries

Cambridge Industries Group（剑桥科技）, or CIG, reaffirmed plans to add at least 10 million units of annual high-speed optical module capacity by the end of 2027. The expanded capacity will be allocated across production sites in China, Malaysia, Mexico and the United States.

Vital Optics Unit Signs InP Substrate Supply Letter of Intent with Coherent

Vital Optics（光智科技）said on November 6 that its controlling subsidiary Guangdong Xianrui Technology（广东先锐科技）had signed a long-term supply letter of intent with Coherent Corp.（高意）. The proposed supply of six-inch indium phosphide substrates from 2027 to 2029 has an estimated transaction value of no less than USD 601 million.

360 DigiTech Announces Q2 2021 Financial Results

During the six months through June, 360 DigiTech's (QFIN:NASDAQ) net profit was CNY 1.548 billion, representing an increase of 76.6% year-on-year.

A Success Tunnel for 360 DigiTech: Business Transformation

China's outstanding loan balance reached a fresh record of CNY 172.75 trillion in 2020 and keeps growing, spurred by the increasing digitalization and booming e-commerce market.